03493nam a22003734u 450000100220000000300060002200500170002800700150004500800410006002000300010102400310013104100080016224501470017025000060031726000160032326400160033930000120035533600260036733700260039333800360041934700210045534700080047652018610048465000410234565000220238665000410240865302690244970000260271870000310274477600360277585600640281185601020287585601420297710.1002/9781394175482Wiley20251030120317.0cr nn 008mam|a240314t2024||||xxu    fs|   |0|| 0|eng||  a9781394175482qelectronic7 a10.1002/97813941754822doi  aeng00aNanocarrier VaccinesbBiopharmaceutics‐Based Fast Track Developmenth[electronic resource]cEdited by Vivek P. Chavda, Vasso Apostolopoulos.  a1  bWileyc2024 1bWileyc2024  a528pp.;  atextbtxt2rdacontent  acomputerbc2rdamedia  aonline resourcebcr2rdacarrier  atext file2rdaft  bPDF  aNANOCARRIER VACCINES This book details the benefits, restrictions, and types of nanoparticles used in the creation of vaccines for the treatment and prevention of illnesses. In nanomedicine and nano-delivery systems, materials in the nanoscale range are used as diagnostic instruments or to administer therapeutic compounds to particular targeted regions in a controlled manner. By delivering precise medications to specified locations and targets, nanotechnology provides several advantages in treating chronic human illnesses. The use of nanomedicine (including chemotherapeutic medicines, biological agents, immunotherapeutic agents, etc.) in the treatment of various diseases has recently seen many notable applications. This book aims to be a single source material for understanding all the current and novel advancements in the field of nanotechnology. In this groundbreaking book the reader will find: biodegradable and non-biodegradable formulations and properties such as size, shape, charge, inertness, efficacy, morphology, and more; show how different nanoparticles, such as lipid-based, viral vector-based, and metal, uphold very significant properties individually, suggesting applicability in various management tactics; examines how genetic information-carrying entities are becoming the norm for eradicating some diseases; gathers an exhaustive amount of information on routes of administration such as the oral route, mucosal immunity, intramuscular, subcutaneous, and intradermal; explores the legal regulations for nanotechnology-based approaches. Audience Researchers and pharmacy students in biomedical engineering and chemical engineering, biotechnology, as well as pharmaceutical and biopharmaceutical industry engineers working in drug discovery, chemical biology, computational chemistry, medicinal chemistry, and bioinformatics. 4aPharmaceutical & Medicinal Chemistry 4aNanobiotechnology 4aClinical Pharmacology & Therapeutics00aVaccines; nanoparticles; immunogenicity; data science; Process Development; Pharmaceuticals; Biopharmaceuticals; Pharma; Nano-Vaccines; Biocompatibility; liposome formulations; Fast-track development; Future Perspectives; Biocompatibility; Antigen Presenting Cells1 aChavda, Vivek P.4edt1 aApostolopoulos, Vasso4edt08iPrinted edition:z978139417468340uhttps://doi.org/10.1002/9781394175482aWiley Online Library40uhttps://onlinelibrary.wiley.com/action/showBook?doi=10.1002%2F9781394175482aWiley Online Library423Cover Imageuhttps://onlinelibrary.wiley.com/cms/asset/2b93530f-31fa-401c-86bc-8739bc8f4808/9781394175482.cover.gifaWiley Online Library